{"disease":{"id":"kidney-transplant-rejection","name":"kidney transplant rejection"},"drugs":{"marketed":[{"drug_id":"ciclosporin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"Ciclosporin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":68,"revenue":"1866.0","mechanism":""},{"drug_id":"cyclosporine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"cyclosporine","company_name":"Novartis AG (originally Sandoz)","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"Calcineurin inhibitor (immunosuppressant)","quality_score":67,"revenue":"1866.0","mechanism":"Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection."},{"drug_id":"tacrolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prograf","generic_name":"TACROLIMUS","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Interferon gamma","drug_class":"Calcineurin Inhibitor Immunosuppressant","quality_score":80,"revenue":"1600","mechanism":"Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell."},{"drug_id":"everolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Afinitor","generic_name":"everolimus","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"Kinase Inhibitor [EPC]","quality_score":67,"revenue":"600","mechanism":"Afinitor works by blocking the mTOR protein, which is involved in cell growth and division."},{"drug_id":"ciclosporine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ciclosporine","company_name":"Hospices Civils de Lyon","drug_phase":"phase_3","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."},{"drug_id":"mycophenolic-acid","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycophenolate","generic_name":"MYCOPHENOLIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"sirolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rapamune","generic_name":"sirolimus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"mTOR Inhibitor Immunosuppressant [EPC]","quality_score":80,"revenue":null,"mechanism":"Rapamune works by binding to the mTOR protein, inhibiting its activity and preventing the growth and proliferation of certain cells."},{"drug_id":"neoral","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neoral","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cyclosporin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cyclosporin","company_name":"Karolinska University Hospital","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"rapamune","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamune","company_name":"Wyeth is now a wholly owned subsidiary of Pfizer","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"rapamycin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamycin","company_name":"Institut National de la Santé Et de la Recherche Médicale, France","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"azathioprine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Imuran","generic_name":"AZATHIOPRINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Purine Antimetabolite [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"mycophenolate","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mycophenolate","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2, Inosine-5'-monophosphate dehydrogenase (IMPDH)","drug_class":"","quality_score":42,"revenue":null,"mechanism":null},{"drug_id":"afinitor","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Afinitor","company_name":"Central European Society for Anticancer Drug Research","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Peptidyl-prolyl cis-trans isomerase FKBP1A, Serine/threonine-protein kinase mTOR","drug_class":"","quality_score":19,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06348446","title":"Tacrolimus Exposure in Kidney Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06496269","title":"Impact of Microvascular Inflammation on Kidney Allograft Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT04091984","title":"The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Natera, Inc.","has_results":false},{"nct_id":"NCT06394596","title":"Predicting Prognostic Factors in Kidney Transplantation Using A Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":4077,"lead_sponsor_name":"Sung Shin","has_results":false},{"nct_id":"NCT03326076","title":"Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"CareDx","has_results":false},{"nct_id":"NCT05306795","title":"Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06505200","title":"Observational Cohort Study Renal Transplantation University Hospitals Leuven","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1891,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03466775","title":"Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":1845,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06016283","title":"Sex Impact on Long-term Outcomes of LDKT","phase":"","overall_status":"COMPLETED","enrollment_count":1276,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03487861","title":"Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04566055","title":"Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"CareDx","has_results":false},{"nct_id":"NCT06365411","title":"GEnomic Medicine in Kidney Transplantation Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT05715853","title":"Prospective Assessment of Rejection in Kidney Transplant (PARK)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"NephroSant","has_results":false},{"nct_id":"NCT06087003","title":"Pediatric Induction Therapy in Kidney Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":958,"lead_sponsor_name":"Gang Chen","has_results":false},{"nct_id":"NCT03582436","title":"Rejection Diagnosis in Kidney Transplants Patients","phase":"","overall_status":"COMPLETED","enrollment_count":824,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04694573","title":"Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Heidelberg University","has_results":false},{"nct_id":"NCT07231328","title":"PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Transplant Genomics, Inc.","has_results":false},{"nct_id":"NCT03652402","title":"Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN","phase":"","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04727788","title":"Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":550,"lead_sponsor_name":"Verici Dx","has_results":false},{"nct_id":"NCT07412470","title":"A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":526,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06314230","title":"Australian Genomics Of Chronic Allograft Dysfunction Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT07145944","title":"To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT02727296","title":"Volatile Anesthetic Protection Of Renal Transplants 2","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT05816486","title":"BIOtechnology Applied to Renal TRansplantation With IMmunobiogram","phase":"","overall_status":"COMPLETED","enrollment_count":443,"lead_sponsor_name":"Biohope Scientific Solutions for Human Health, S.L.","has_results":false},{"nct_id":"NCT05747274","title":"SRDK0921_ Analytical Performance Study","phase":"","overall_status":"COMPLETED","enrollment_count":439,"lead_sponsor_name":"BioMAdvanced Diagnostics","has_results":false},{"nct_id":"NCT03206801","title":"Urine CXCL10 Monitoring Trial in Kidney Transplant","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of Manitoba","has_results":false},{"nct_id":"NCT05897047","title":"The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":384,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT06351488","title":"Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection","phase":"","overall_status":"RECRUITING","enrollment_count":319,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03874299","title":"The TOGETHER Project - Kidney RNA-seq Validation","phase":"","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03789006","title":"Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University of Khartoum","has_results":false},{"nct_id":"NCT06291103","title":"Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT06025240","title":"Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients","phase":"","overall_status":"RECRUITING","enrollment_count":282,"lead_sponsor_name":"Liverpool University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT05325008","title":"A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT05872568","title":"Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":270,"lead_sponsor_name":"Zhishui Chen","has_results":false},{"nct_id":"NCT04601155","title":"Transition of Renal Patients Using AlloSure Into Community Kidney Care","phase":"","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"CareDx","has_results":false},{"nct_id":"NCT05727709","title":"Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":220,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT03134625","title":"Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06013358","title":"ddcfDNA in Kidney Transplant Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04526431","title":"Tacrolimus Pharmacokinetic Subpopulations","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT05779124","title":"BAFF/APRIL in Kidney Transplant Rejection Risk Assessment","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":176,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05836636","title":"Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":172,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT03488771","title":"Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Clinical Hospital Merkur","has_results":false},{"nct_id":"NCT06476717","title":"Donor-derived Cell-free DNA in Kidney Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT04851145","title":"Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04166149","title":"Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT04953715","title":"Microbiome and Immunosuppression: The Mission Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"The University of Texas Medical Branch, Galveston","has_results":false},{"nct_id":"NCT06825117","title":"PRObiotics for KIdney Transplantation","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":132,"lead_sponsor_name":"University Hospital, Udine, Italy","has_results":false},{"nct_id":"NCT04388930","title":"The Microbiota in Kidney Donation and Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"Royal Free Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT05983770","title":"Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Eledon Pharmaceuticals","has_results":false},{"nct_id":"NCT04154267","title":"Protocol Biopsies in High-risk Renal Transplant Recipients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":119,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}